Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56201 - 56225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	GPC3	2719	downregulated	panobinostat results in decreased expression of GPC3 mRNA	Xq26.2	A21037
Panobinostat	Approved Investigational	GPC4	2239	downregulated	panobinostat results in decreased expression of GPC4 mRNA	Xq26.2	A21037
Panobinostat	Approved Investigational	GPC6	10082	downregulated	panobinostat results in decreased expression of GPC6 mRNA	13q31.3-q32.1	A21037
Panobinostat	Approved Investigational	GPD1L	23171	upregulated	panobinostat results in increased expression of GPD1L mRNA	3p22.3	A21037
Panobinostat	Approved Investigational	GPR173	54328	downregulated	panobinostat results in decreased expression of GPR173 mRNA	Xp11.22	A21037
Panobinostat	Approved Investigational	GPR27	2850	downregulated	panobinostat results in decreased expression of GPR27 mRNA	3p13	A21037
Panobinostat	Approved Investigational	GPR37	2861	upregulated	panobinostat results in increased expression of GPR37 mRNA	7q31.33	A21037
Panobinostat	Approved Investigational	GREM1	26585	upregulated	panobinostat results in increased expression of GREM1 mRNA	15q13.3	A21037
Panobinostat	Approved Investigational	GRHL3	57822	upregulated	panobinostat results in increased expression of GRHL3 mRNA	1p36.11	A21037
Panobinostat	Approved Investigational	GRIA3	2892	downregulated	panobinostat results in decreased expression of GRIA3 mRNA	Xq25	A21037
Panobinostat	Approved Investigational	GRIK3	2899	downregulated	panobinostat results in decreased expression of GRIK3 mRNA	1p34.3	A21037
Panobinostat	Approved Investigational	GRM3	2913	downregulated	panobinostat results in decreased expression of GRM3 mRNA	7q21.11-q21.12	A21037
Panobinostat	Approved Investigational	GYPC	2995	upregulated	panobinostat results in increased expression of GYPC mRNA	2q14.3	A21037
Panobinostat	Approved Investigational	H2AFY	9555	downregulated	panobinostat results in decreased expression of H2AFY mRNA	5q31.1	A21037
Panobinostat	Approved Investigational	H2BFXP	767811	downregulated	panobinostat results in decreased expression of H2BFXP mRNA	Xq22.2	A21037
Panobinostat	Approved Investigational	HACD1	9200	upregulated	panobinostat results in increased expression of HACD1 mRNA	10p12.33	A21037
Panobinostat	Approved Investigational	HAPLN1	1404	upregulated	panobinostat results in increased expression of HAPLN1 mRNA	5q14.3	A21037
Panobinostat	Approved Investigational	HAS2	3037	upregulated	panobinostat results in increased expression of HAS2 mRNA	8q24.13	A21037
Panobinostat	Approved Investigational	HDAC8	55869	upregulated	panobinostat results in increased expression of HDAC8 mRNA	Xq13.1	A21037
Panobinostat	Approved Investigational	HEG1	57493	downregulated	panobinostat results in decreased expression of HEG1 mRNA	3q21.2	A21037
Panobinostat	Approved Investigational	HERC5	51191	upregulated	panobinostat results in increased expression of HERC5 mRNA	4q22.1	A21037
Panobinostat	Approved Investigational	HES2	54626	upregulated	panobinostat results in increased expression of HES2 mRNA	1p36.31	A21037
Panobinostat	Approved Investigational	HES5	388585	downregulated	panobinostat results in decreased expression of HES5 mRNA	1p36.32	A21037
Panobinostat	Approved Investigational	HESX1	8820	downregulated	panobinostat results in decreased expression of HESX1 mRNA	3p14.3	A21037
Panobinostat	Approved Investigational	HEY2	23493	upregulated	panobinostat results in increased expression of HEY2 mRNA	6q22.31	A21037

Displaying entries 56201 - 56225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability